Rankings
▼
Calendar
FLGT Q1 2016 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena
FLGT
Fulgent Genetics, Inc.
$449M
Q1 2016 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$3M
Gross Profit
$2M
62.1% margin
Operating Income
-$615,000
-17.9% margin
Net Income
-$543,000
-15.8% margin
EPS (Diluted)
$-0.04
Cash Flow
Operating Cash Flow
$875,000
Free Cash Flow
$698,000
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$7M
Total Liabilities
$1M
Stockholders' Equity
$6M
Cash & Equivalents
$1M
← FY 2016
All Quarters
Q2 2016 →